Latest News

GENERATION HD2 Trial of Huntington Agent Tominersen Amended to Include Only Higher Dose
GENERATION HD2 Trial of Huntington Agent Tominersen Amended to Include Only Higher Dose

April 24th 2025

Roche has updated its phase 3 GENERATION HD2 trial to continue testing only the higher 100 mg dose of tominersen, following interim data favoring its potential clinical benefit in Huntington disease.

Alex Jaimes, MD  (Credit: X)
Switching Between Anti-CGRP Monoclonal Antibodies Reduces Headache Days in Non-Responders

April 24th 2025

NeuroOne Submits OneRF Ablation System Application for Treating Trigeminal Neuralgia-Related Facial Pain
NeuroOne Submits OneRF Ablation System Application for Treating Trigeminal Neuralgia-Related Facial Pain

April 23rd 2025

Rohan Hoare, PhD  (Credit: Epiminder)
FDA Grants Authorization to Epiminder’s Implantable Continuous EEG Monitor for Epilepsy Treatment

April 23rd 2025

GLP-1 Agonists and SGLT2 Inhibitors Considered More Effective for Lowering Alzheimer Disease Risk
GLP-1 Agonists and SGLT2 Inhibitors Considered More Effective for Lowering Alzheimer Disease Risk

April 23rd 2025

Coverage of the 2025 AAN Annual Meeting

Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in San Diego.

AAN 2025

Conference Coverage

View All
Unveiling ARCUS Gene Editing Platform and Its Potential in DMD: Cassandra Gorsuch, PhD
Unveiling ARCUS Gene Editing Platform and Its Potential in DMD: Cassandra Gorsuch, PhD

April 23rd 2025

Breaking Down Oculopharyngeal Muscular Dystrophy: From Clinical Gaps to Genetic Gains
Breaking Down Oculopharyngeal Muscular Dystrophy: From Clinical Gaps to Genetic Gains

April 22nd 2025

Rethinking Alzheimer Diagnosis and Disease Staging: Clifford Jack, MD
Rethinking Alzheimer Diagnosis and Disease Staging: Clifford Jack, MD

April 21st 2025

Exploring a New Oral Option for Alzheimer Treatment With Sonya Miller
Exploring a New Oral Option for Alzheimer Treatment With Sonya Miller

April 21st 2025

Video Series
Video Interviews
Podcasts

Most Recent

© 2025 MJH Life Sciences

All rights reserved.